Capula Management’s Abiomed Inc ABMD Stock Holding History

Capula Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,389	Closed	-$434K	–	1113
2021 Q2	$434K	Buy	+1,389	New	+$426K	0.01%	485

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Capula Management's ABMD Position: Q3 2021 in Review

Capula Management sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 1,389 shares — an estimated $434K sold.

Capula Management first reported a position in ABMD in Q2 2021 and held it in 1 quarter. The position peaked at $434K in Q2 2021. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

Capula Management reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
Capula Management sold 1,389 Abiomed Inc shares in Q3 2021, an estimated $434K.
Capula Management first reported a position in Abiomed Inc in Q2 2021 and held it in 1 quarter.
Capula Management's Abiomed Inc position peaked at $434K in Q2 2021.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Capula Management's 13F filing for Q3 2021, filed 15 Nov 2021.